Araştırma Makalesi

Is the Systemic Immune-Inflammation Index Associated with the Prognosis and Severity of Bell’s Palsy?

Cilt: 9 Sayı: 4 25 Aralık 2024
PDF İndir
TR EN

Is the Systemic Immune-Inflammation Index Associated with the Prognosis and Severity of Bell’s Palsy?

Abstract

Objective: To investigate the effect of newly defined systemic immune-inflammation index levels on the diagnosis, prognosis, and severity of Bell's palsy. Materials and Methods: The study group was formed from patients diagnosed with Bell's palsy. Calculated ratios with the data obtained from the complete blood count examinations taken before the treatment were statistically investigated for the diagnosis, prognosis, and severity of the disease. Results: We did not determine any statistically significant correlation between the determined facial paralysis stages and the investigated ratios. Similarly, there was no correlation between the first and sixth-month recovery rates of the study group and the investigated parameters (p>0.05). In addition, differences in parameters between the control and study groups were not statistically significant. Conclusions: The results of the presented study contain differences from the current literature. In addition, it provides new information about the effect of the systemic immune-inflammation index on the prognosis of Bell's palsy. Considering the outcomes of research on hematological parameters is important, as various factors can impact them.

Keywords

Etik Beyan

Our study was approved by the Sakarya University Ethics Committee (Date: 12.02.2021, decision no: 84). The study was carried out following the international declaration, guidelines, etc.

Kaynakça

  1. Stjernquist-Desatnik A, Skoog E, Aurelius E. Detection of herpes simplex and varicella-zoster viruses in patients with Bell's palsy by the polymerase chain reaction technique. Ann Otol Rhinol Laryngol. 2006;115(4):306-311. doi:10.1177/000348940611500410
  2. Lagalla G, Logullo F, Di Bella P, Provinciali L, Ceravolo MG. Influence of early high-dose steroid treatment on Bell's palsy evolution. Neurol Sci. 2002;23(3):107-112. doi:10.1007/s100720200035
  3. Oya R, Takenaka Y, Imai T, et al. Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Hematologic Markers of Bell's Palsy: A Meta-analysis. Otol Neurotol. 2019;40(5):681-687. doi:10.1097/MAO.0000000000002166
  4. Ulu S, Ulu MS, Bucak A, Ahsen A, Yucedag F, Aycicek A. Neutrophil-to-lymphocyte ratio as a new, quick, and reliable indicator for predicting diagnosis and prognosis of idiopathic sudden sensorineural hearing loss. Otol Neurotol. 2013;34(8):1400-1404. doi:10.1097/MAO.0b013e31829b57df
  5. Kumbul YÇ, Yasan H, Tüz M, Okur E, Sivrice ME, Büyükçelik B. Prognostic Evaluation of Systemic Immune Inflammation Index in Sudden Idiopathic Sensorineural Hearing Loss. SDÜ Tıp Fakültesi Dergisi. 2020;27(4):455-461. doi.org/10.17343/sdutfd.742573
  6. Kınar A, Ulu Ş, Bucak A, Kazan E. Can the Systemic Immune-Inflammation Index (SII) be a prognostic factor of Bell's palsy patients? Neurol Sci. 2021;42(8):3197-3201. doi:10.1007/s10072-020-04921-5
  7. Zhang W, Xu L, Luo T, Wu F, Zhao B, Li X. The etiology of Bell's palsy: a review. J Neurol. 2020;267(7):1896-1905. doi:10.1007/s00415-019-09282-4
  8. Yilmaz M, Tarakcioglu M, Bayazit N, Bayazit YA, Namiduru M, Kanlikama M. Serum cytokine levels in Bell's palsy. J Neurol Sci. 2002;197(1-2):69-72. doi:10.1016/s0022-510x(02)00049-7

Ayrıntılar

Birincil Dil

İngilizce

Konular

Kulak Burun Boğaz

Bölüm

Araştırma Makalesi

Erken Görünüm Tarihi

21 Aralık 2024

Yayımlanma Tarihi

25 Aralık 2024

Gönderilme Tarihi

30 Ekim 2024

Kabul Tarihi

29 Kasım 2024

Yayımlandığı Sayı

Yıl 2024 Cilt: 9 Sayı: 4

Kaynak Göster

AMA
1.Kara A, Elden H. Is the Systemic Immune-Inflammation Index Associated with the Prognosis and Severity of Bell’s Palsy? OTSBD. 2024;9(4):373-378. doi:10.26453/otjhs.1576219

Creative Commons Lisansı
 

Online Türk Sağlık Bilimleri Dergisi Creative Commons Atıf-GayriTicari 4.0 Uluslararası Lisansı ile lisanslanmıştır.

Bu, Creative Commons Atıf Lisansı (CC BY-NC 4.0) şartları altında dağıtılan açık erişimli bir dergidir. Orijinal yazar(lar) veya lisans verenin adı ve bu dergideki orijinal yayının kabul görmüş akademik uygulamaya uygun olarak atıfta bulunulması koşuluyla, diğer forumlarda kullanılması, dağıtılması veya çoğaltılmasına izin verilir. Bu şartlara uymayan hiçbir kullanım, dağıtım veya çoğaltmaya izin verilmez.

Makale gönderme süreçleri ve "Telif Hakkı Devir Formu" hakkında yardım almak için tıklayınız.